drugset / Trial / NCT03008460

Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy

NCT03008460 ↗

Phase 3 Completed 250 enrolled Ipsen
RandomizedParallel-groupSingle-blindOther

Summary

The purpose of the protocol is to demonstrate that Eziclen®/Izinova®, an osmotic sulphate-based laxative preparation given on the day before colonoscopy has non-inferior efficacy to Klean-Prep® (polyethylene glycol (PEG)-electrolytes) on colon cleansing in adolescents aged 12 to 17 years (inclusive) with a body weight \>40 kg, scheduled to undergo a colonoscopy for a routinely accepted diagnostic indication.

Timeline

Start
2017-10-15
Primary completion
2020-02-24
Completion
2020-06-29

Outcome

Missed primary endpoint

registry analysis (non-inferiority test); Eziclen®/Izinova® vs Klean-Prep®; p = 0.0907; Adjusted treatment difference -7.61 (95% CI -18.45 to 3.24) NCT03008460 ↗

paper CONCLUSIONS: Non-inferiority of OSS to PEG was not demonstrated PMID 36821851 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Eziclen Other / unclassified — Oral
Comparator Klean-Prep® Other / unclassified — Oral